Grant Street Asset Management’s Twist Bioscience TWST Stock Holding History

Grant Street Asset Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-320	Closed	-$40K	–	168
2021 Q1	$40K	Hold	320	–	–	0.02%	117
2020 Q4	$45K	Buy	+320	New	+$35.5K	0.02%	94

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Grant Street Asset Management's TWST Position: Q2 2021 in Review

Grant Street Asset Management sold out of Twist Bioscience (TWST) in Q2 2021, closing a stake of 320 shares — an estimated $40K sold.

Grant Street Asset Management first reported a position in TWST in Q4 2020 and held it in 2 quarters. The position peaked at $45K in Q4 2020. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2021.

Grant Street Asset Management reported no remaining Twist Bioscience position as of Q2 2021 after selling out during the quarter.
Grant Street Asset Management sold 320 Twist Bioscience shares in Q2 2021, an estimated $40K.
Grant Street Asset Management first reported a position in Twist Bioscience in Q4 2020 and held it in 2 quarters.
Grant Street Asset Management's Twist Bioscience position peaked at $45K in Q4 2020.
244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2021.

Based on Grant Street Asset Management's 13F filing for Q2 2021, filed 10 Aug 2021.